Home » Stocks » PTIX » Financials

Protagenic Therapeutics, Inc. (PTIX)

Stock Price: $2.12 USD -0.11 (-4.93%)
Updated Jul 27, 2021 4:00 PM EDT - Market closed

Income Statement (Annual)

Numbers in millions USD. Fiscal year is January - December.
Year202020192018201720162015201420132012201020092008200720062005
Revenue-------0.0921.1940.0369.0911436.9818.725.87
Revenue Growth--------99.6%-47.06%-42.07%-39.33%207.94%97.54%219.09%-
Cost of Revenue--------15.6822.5143.3174.5429.050.600.27
Gross Profit-------0.095.5117.5125.7839.347.9318.125.60
Selling, General & Admin1.851.281.431.651.410.57-0.770.9815.2913.1223.0926.038.9316.654.91
Research & Development0.700.810.880.720.420.46---20.1910.569.753.15--
Other Operating Expenses0.000.000.000.000.400.000.000.137.036.4920.991211.350.000.00
Operating Expenses2.552.092.312.372.231.03-0.771.1122.3139.8154.6415613.4316.654.91
Operating Income-2.55-2.09-2.31-2.37-2.23-1.030.77-1.03-16.80-22.30-28.86-117-5.501.470.69
Interest Expense / Income0.250.02--0.010.010.00--0.020.080.150.020.010.01
Other Expense / Income-0.25-0.350.24-0.110.04-0.011.850.000.00-1.52-0.11-0.62-0.170.080.03
Pretax Income-2.55-1.75-2.56-2.26-2.28-1.02-1.08-1.03-16.80-20.79-28.83-117-5.351.390.66
Income Tax----------1.070.64-0.85-1.200.710.27
Net Income-2.55-1.75-2.56-2.26-2.28-1.02-1.08-1.03-16.80-19.73-29.47-116-4.150.680.39
Shares Outstanding (Basic)10.3410.2610.2610.265.316.610.030.010.000.000.000.000.000.00-
Shares Outstanding (Diluted)10.3410.2610.2610.265.316.610.030.010.000.000.000.000.000.00-
Shares Change0.76%0%0%93.39%-19.77%25466.7%299.98%68.94%987.5%5.39%-3.19%88.52%56.41%--
EPS (Basic)-0.25-0.17-0.25-0.22-0.43-0.15--154.64-4,329.92-55,979.68-88,299.44-335,878.08-22,886.725,567.04927,849.28
EPS (Diluted)-0.25-0.17-0.25-0.22-0.43-0.15--154.64-4,329.92-55,979.68-88,299.44-335,878.08-22,886.725,567.04927,849.28
EPS Growth--------------99.4%-
Free Cash Flow Per Share-0.13-0.05-0.10-0.13-0.22-0.06-30.58-47.78-146.55-32,047.03-11,074.736,748.25-29,892.797,272.48826,086.96
Gross Margin-------100%26%43.8%37.3%34.5%21.4%96.8%95.4%
Operating Margin--------1,208.2%-79.3%-55.7%-41.8%-102.8%-14.9%7.9%11.8%
Profit Margin--------1208.2%-79.3%-49.3%-42.7%-101.7%-11.2%3.6%6.6%
FCF Margin--------363.5%-2.6%-28.2%-5.4%2.0%-14.8%4.6%5.5%
Effective Tax Rate-------------51.1%41.1%
EBITDA-2.30-1.73-2.56-2.26-2.27-1.01-1.08-1.03-14.20-19.13-25.06-111-3.981.420.68
EBITDA Margin--------1208.2%-67%-47.8%-36.3%-97.1%-10.8%7.6%11.5%
EBIT-2.30-1.74-2.56-2.26-2.27-1.01-1.08-1.03-16.80-20.78-28.75-116-5.331.400.67
EBIT Margin--------1,208.2%-79.3%-51.9%-41.6%-102.3%-14.4%7.5%11.4%

Showing 15 of 22 years

7 more years are available